BiotechTube
Home/StrideBio/Aravind Asokan, Ph.D.
AA

Aravind Asokan, Ph.D.

Founder & Chief Scientific Advisor

StrideBio

Therapeutic Areas

NeurologyCardiovascularMetabolicGenetic Disorders

StrideBio Pipeline

DrugIndicationPhase
STRX-110SLC13A5 Deficiency (pediatric epilepsy)Phase 1/2
Friedreich's Ataxia ProgramFriedreich's AtaxiaPreclinical
Cardiovascular ProgramUndisclosed Genetic Cardiovascular DiseasePreclinical

Leadership Team at StrideBio

SS
Sapan Shah, Ph.D.
Chief Executive Officer
PZ
Patricia Zilliox, Ph.D.
Chief Development Officer
CD
Cynthia Dunbar, M.D.
Chief Medical Officer
View full StrideBio profile